Bristol-Myers Squibb / SPOTme® Skin Cancer Screening Program
Bristol-Myers Squibb donated its Melanoma Exposed™ program through a charitable grant to support the expansion of the Academy’s skin cancer detection efforts. The Academy has integrated Melanoma Exposed™ into its national skin cancer screening program and rebranded all of its screenings as SPOTme®, a part of the Academy's larger SPOT Skin Cancer™ initiative.
Through this initiative, the Academy hopes to teach more people how to spot skin cancer and expand the number of free skin cancer screenings throughout the country.
Total contribution: More than $4.3 million and in-kind assets to support SPOTme® over the next five years.
Partner since: 2014 More information: www.bms.com